References
- Pirnay JP, De Vos D, Verbeken G. Clinical application of bacteriophages in Europe. Microbiol Aust. 2019;40:8–15. Available from: http://microbiology.publish.csiro.au/?paper=MA19010
- Schooley RT, Biswas B, Gill JJ, et al. Erratum for Schooley et al., “Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection.” Antimicrob Agents Chem. 2018;62(12). DOI:10.1128/AAC.02221-18.
- Dedrick RM, Guerrero-Bustamante CA, Garlena RA, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25(5):730–733.
- Międzybrodzki R, Hoyle N, Zhvaniya F, et al. Current updates from the long-standing phage research centers in Georgia, Poland and Russia. In: Harper D, Abedon S, Burrowes B, et al., editors. Bacteriophages. Switzerland: Springer, Cham; 2018. p. 1–31. ISBN 978-3-319-40598-8.
- Górski A, Międzybrodzki R, Weber-Dąbrowska B, et al. Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front Microbiol. 2016;7(1515):1–9.
- Verbeken G, Pirnay JP, Lavigne R, et al. Call for a dedicated European legal framework for bacteriophage therapy. Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):117–129.
- Huys I, Pirnay JP, Lavigne R, et al. Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy. EMBO Rep. 2013 Nov;14(11):951–954.
- Nguyen S, Baker K, Padman B, et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. MBio. 2017;8(6):e01874–17.
- Lehti TA, Pajunen MI, Skog MS, et al. Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Nat Commun. 2017;8(1):1915.
- Górski A, Wazna E, Dabrowska BW, et al. Bacteriophage translocation. FEMS Immunol Med Microbiol. 2006;46(3):313–319. .
- Gogokhia L, Buhrke K, Rickesha B, et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe. 2019;25(2):285–299.e8.
- Sweere JM, Van Belleghem JD, Ishak H, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363:6434.
- Górski A, Międzybrodzki R, Borysowski J, et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res. 2012;83:41–71.
- Górski A, Dąbrowska K, Międzybrodzki1 R, et al. Phages and immunomodulation. Future Microbiol. 2017;12:10.
- Van Belleghem JD, Clement F, Merabishvili M, et al. Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. Sci Rep. 2017;7:8004.
- Mirzaei MK, Haileselassie Y, Navis M, et al. Morphologically distinct Escherichia coli bacteriophages differ in their efficacy and ability to stimulate cytokine release in vitro. Front Microbiol. 2016;7:437.
- Górski A, Bollyky PL, Przybylski M, et al. Perspectives of phage therapy in non-bacterial infections. Front Microb. 2019. DOI:10.3389/fmicb.2018.03306.